Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Arroyo

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Journal of Medical Genetics|April 22, 2014
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosisConcepción Núñez, M Carmen Cénit, Roberto Alvarez-Lafuente, et al.
European Journal of Human Genetics : EJHG|February 21, 2008
IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis riskAlfonso Martínez, José Luis Santiago, M Carmen Cénit, et al.
Plos One|February 25, 2012
DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bandsEmilio G de la Concha, María L Cavanillas, M Carmen Cénit, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 8, 2014
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosisAlberto Fernández-Jaén, Daniel Martín Fernández-Mayoralas, Ana Laura Fernández-Perrone, et al.
Clinical Immunology (Orlando, Fla.)|July 13, 2010
Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosisLuisa M Villar, Mercedes Espiño, María L Cavanillas, et al.
European Journal of Human Genetics : EJHG|February 25, 2010
Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis riskMaría L Cavanillas, Antonio Alcina, Concepción Núñez, et al.
Clinical Neuropharmacology|November 24, 2016
Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in MadridVictoria Galán Sánchez-Seco, Ignacio Casanova-Peño, Roberto Álvarez-Lafuente, et al.
Frontiers in Immunology|April 8, 2026
HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosisStefano Ruberto, Maria I Dominguez-Mozo, Luisa María Villar, et al.
Revista De Neurologia|June 11, 2014
Biomarkers in multiple sclerosis: an update for 2014Oscar Fernandez, Roland Martin, Alex Rovira, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 21, 2022
Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT studySibyl Wray, Francois Jacques, Tamara A Miller, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Journal of Medical Genetics|April 22, 2014
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosisConcepción Núñez, M Carmen Cénit, Roberto Alvarez-Lafuente, et al.
European Journal of Human Genetics : EJHG|February 21, 2008
IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis riskAlfonso Martínez, José Luis Santiago, M Carmen Cénit, et al.
Plos One|February 25, 2012
DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bandsEmilio G de la Concha, María L Cavanillas, M Carmen Cénit, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 8, 2014
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosisAlberto Fernández-Jaén, Daniel Martín Fernández-Mayoralas, Ana Laura Fernández-Perrone, et al.
Clinical Immunology (Orlando, Fla.)|July 13, 2010
Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosisLuisa M Villar, Mercedes Espiño, María L Cavanillas, et al.
European Journal of Human Genetics : EJHG|February 25, 2010
Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis riskMaría L Cavanillas, Antonio Alcina, Concepción Núñez, et al.
Clinical Neuropharmacology|November 24, 2016
Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in MadridVictoria Galán Sánchez-Seco, Ignacio Casanova-Peño, Roberto Álvarez-Lafuente, et al.
Frontiers in Immunology|April 8, 2026
HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosisStefano Ruberto, Maria I Dominguez-Mozo, Luisa María Villar, et al.
Revista De Neurologia|June 11, 2014
Biomarkers in multiple sclerosis: an update for 2014Oscar Fernandez, Roland Martin, Alex Rovira, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 21, 2022
Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT studySibyl Wray, Francois Jacques, Tamara A Miller, et al.
Pageof 12